TransMedics Group, Inc. - Common Stock (TMDX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
TMDX on Nasdaq
Shares outstanding
33,940,151
Price per share
$121.65
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
37,128,223
Total reported value
$4,166,150,614
% of total 13F portfolios
0.01%
Share change
+297,662
Value change
-$11,137,750
Number of holders
385
Price from insider filings
$121.65
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TransMedics Group, Inc. - Common Stock (TMDX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +16% $467,547,574 +$64,260,663 5,058,396 +16% FMR LLC 31 Mar 2025
BlackRock, Inc. 15% $664,054,661 4,955,262 BlackRock, Inc. 30 Jun 2025

As of 30 Sep 2025, 385 institutional investors reported holding 37,128,223 shares of TransMedics Group, Inc. - Common Stock (TMDX). This represents 109% of the company’s total 33,940,151 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of TransMedics Group, Inc. - Common Stock (TMDX) together control 80% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 5,331,598 +2.1% 0.01% $598,205,291
FMR LLC 15% 5,064,370 +0.81% 0.03% $568,222,298
VANGUARD GROUP INC 11% 3,605,607 +0.27% 0.01% $404,549,105
STATE STREET CORP 3.8% 1,279,541 -0.73% 0% $143,564,500
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 3.2% 1,069,492 +12% 0.03% $119,997,002
MACQUARIE GROUP LTD 2.7% 906,268 -4.8% 0.12% $101,683,000
UBS Group AG 2.5% 856,063 +80% 0.02% $96,050,269
GEODE CAPITAL MANAGEMENT, LLC 2.4% 813,571 +1.1% 0.01% $91,295,654
Driehaus Capital Management LLC 2.2% 738,158 -14% 0.59% $82,821,328
GOLDMAN SACHS GROUP INC 2.1% 703,578 +122% 0.01% $78,941,452
Hood River Capital Management LLC 2% 678,437 -0.21% 0.9% $76,120,631
TWO SIGMA INVESTMENTS, LP 1.9% 635,394 +54% 0.11% $71,291,207
MORGAN STANLEY 1.6% 547,819 -25% 0% $61,465,531
EVENTIDE ASSET MANAGEMENT, LLC 1.6% 547,296 -0.01% 1% $61,408,364
MARSHALL WACE, LLP 1.6% 541,678 -0.93% 0.07% $60,776,271
DIMENSIONAL FUND ADVISORS LP 1.3% 450,993 +20% 0.01% $50,602,112
TWO SIGMA ADVISERS, LP 1.2% 423,300 +54% 0.1% $47,494,260
PRICE T ROWE ASSOCIATES INC /MD/ 1.2% 398,160 +189% 0% $44,675,000
JPMORGAN CHASE & CO 1.2% 392,356 -15% 0% $44,022,343
EMERALD ADVISERS, LLC 1.1% 387,588 -12% 1.4% $43,487,374
Invesco Ltd. 1.1% 385,804 -19% 0.01% $43,287,209
BRAIDWELL LP 1% 351,248 +38% 1.2% $39,410,026
NORTHERN TRUST CORP 1% 347,469 -1.5% 0% $38,986,022
WASATCH ADVISORS LP 0.96% 325,202 -3% 0.2% $36,487,664
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.95% 320,787 +1.8% 0.01% $35,992,301

Institutional Holders of TransMedics Group, Inc. - Common Stock (TMDX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 429,064 $52,495,350 +$4,085,167 $121.65 41
2025 Q3 37,128,223 $4,166,150,614 -$11,137,750 $112.20 385
2025 Q2 36,786,193 $4,927,662,357 -$289,195,543 $134.01 366
2025 Q1 39,009,472 $2,625,618,476 +$165,932,691 $67.28 295
2024 Q4 36,855,938 $2,297,784,694 -$388,696,786 $62.35 308
2024 Q3 36,492,550 $5,723,369,932 +$61,413,519 $157.00 365
2024 Q2 33,743,529 $5,082,407,329 +$90,020,373 $150.62 331
2024 Q1 34,019,976 $2,515,517,054 -$71,270,565 $73.94 251
2023 Q4 34,973,168 $2,760,564,347 -$4,091,949 $78.93 244
2023 Q3 34,944,103 $1,913,888,694 +$75,708,281 $54.75 218
2023 Q2 32,524,695 $2,731,143,204 +$226,755,585 $83.98 238
2023 Q1 29,891,511 $2,263,659,591 +$69,279,751 $75.73 221
2022 Q4 28,992,696 $1,789,417,886 +$38,499,424 $61.72 196
2022 Q3 28,283,349 $1,180,766,429 +$229,245,326 $41.74 174
2022 Q2 22,873,577 $719,448,960 +$66,828,071 $31.45 129
2022 Q1 20,846,434 $561,189,812 +$24,725,042 $26.94 107
2021 Q4 20,080,660 $384,713,814 +$27,430,654 $19.16 116
2021 Q3 19,228,003 $636,263,034 +$13,347,336 $33.09 116
2021 Q2 18,779,205 $623,049,047 +$1,144,101 $33.18 117
2021 Q1 18,628,828 $772,924,082 -$21,007,487 $41.49 104
2020 Q4 21,299,571 $423,671,614 -$4,482,122 $19.90 67
2020 Q3 20,827,226 $287,000,555 +$6,185,866 $13.78 71
2020 Q2 20,159,299 $361,233,740 +$92,950,873 $17.92 68
2020 Q1 15,072,652 $182,072,226 -$2,049,598 $12.08 53
2019 Q4 14,958,642 $284,357,755 -$13,693 $19.01 59
2019 Q3 14,301,117 $336,971,808 +$4,714,704 $23.75 49
2019 Q2 11,228,228 $311,861,739 +$311,859,996 $28.99 59
2019 Q1 54 $2,000 $37.04 1